The IV Therapy treatment sessions last 45 minutes, while the NAD+ treatment sessions last between one hour to one hour and a half
Limma Powers Differential Expression Analyses for Rna-Sequencing and Microarray Studies
Makimura H, Feldpausch MN, Rope AM, Hemphill LC, Torriani M, Lee H, et al
That is the most substantial human outcome data currently available for a compound that people are sourcing and injecting based on internet research.[4,5] BPC-157 has been used in Phase II trials for ulcerative colitis and multiple sclerosis.[1,2] Comprehensive published results from those trials are not available in the medical literature
where the liver has become inflamed), fibrosis (with the formation of scar tissue) and finally cirrhosis (permanent damage that can lead to liver failure and cancer)